AI assistant
Inogen Inc — Director's Dealing 2021
Mar 4, 2021
33625_dirs_2021-03-03_14542f64-49bd-4a84-8cd7-a1b19a453fef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-03-01
Reporting Person: Shabshab Nabil (Director, CEO and President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Restricted Stock Unit | $ | A | 16936 | Acquired | Common Stock (16936) | Direct | |
| 2021-03-01 | Restricted Stock Unit | $ | A | 18818 | Acquired | Common Stock (18818) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F2: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years.
F3: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years.